San Diego biotech Molecular Assemblies Inc. has appointed Michael J. Kamdar as CEO and director.

Kamdar previously served as president of Ciclofilin Pharmaceuticals Inc., a biopharmaceutical fim in San Diego that merged with New Jersey-based ContraVir Pharmaceuticals Inc. this summer.

Before that, he served as chief business officer and founder of Seattle-based VentiRx Pharmaceuticals Inc., and as chief financial officer of San Diego-based Anadys Pharmaceuticals Inc. (which was acquired by Roche Holdings AG for $230 million).

Throughout his career, Kamdar raised hundreds of millions of dollars to fund development and commercialization of pharmaceutical products and completed numerous strategic and corporate transactions totaling more than $1 billion, according to a Molecular Assemblies news release.

"Speaking for the rest of the team at Molecular Assemblies, we are very pleased to have Mike joining us in this exciting endeavor,” said William Efcavitch, co-founder of Molecular Assemblies, in a statement. “He brings skills and experience that complement that of the founders. Molecular Assemblies now has all of the necessary elements to take a leadership role in making DNA the industrial polymer of the 21stCentury."